Drs. Asselah, Younan, and Ma share Day 2 highlights from ESMO 2025, noting encouraging results across breast cancer studies, with special mentions to DESTINY-Breast11, DESTINY-Breast05, ASCENT-03, and TROPION-Breast02 — and more exciting updates to come tomorrow.
